Literature DB >> 11144890

Epidemiology and etiology of premalignant and malignant urothelial changes.

S M Cohen1, T Shirai, G Steineck.   

Abstract

Bladder neoplasms are common around the world. Incidences are particularly high in the Nile River Valley secondary to schistosomiasis, which is frequently associated with the development of squamous cell carcinoma similar to that of other chronic inflammatory processes of the lower urinary tract. However, elsewhere, most bladder tumors are of the urothelial (transitional) cell type. There is a marked male predominance and there are extensive racial differences. It is predominantly a neoplasm that occurs in patients aged >50 years. Urothelial carcinomas comprise two distinct diseases both biologically and molecularly: a low-grade papillary tumor which frequently recurs; and a high-grade malignancy which can present as dysplasia or carcinoma in situ, but frequently presents as invasive disease. However, epidemiological investigations of urothelial malignancies have generally not distinguished between preneoplastic and invasive neoplasms or between these two types of urothelial neoplasms. It is recommended that future studies should distinguish between these entities. The most common etiologic factor of urothelial malignancies besides schistosomiasis is cigarette smoking. In addition, numerous specific chemicals have been identified as bladder carcinogens in humans, some relating to specific occupational exposures. Bladder carcinogens include aromatic amines and amides, such as 4-aminobiphenyl, benzidine, 2-naphthylamine and phenacetin-containing analgesics, and certain cancer chemotherapeutic agents, such as phosphoramide mustards. More recently, occupational exposure to various combustion gases, such as diesel exhaust, has been related to an increased risk of developing bladder neoplasms. Also, exposure to chlorination by-products in drinking water and to arsenic has been suggested as increasing the risk of bladder neoplasia. As numerous specific chemicals appear to be related to the development of bladder tumors, various polymorphisms of enzymes involved in their metabolism have been suggested as affecting the susceptibility to their carcinogenicity. This has been particularly true with respect to the role of acetyltransferases in relation to aromatic amine carcinogenesis. Dietary influences have also been suggested as affecting bladder neoplasia susceptibility. Various heterocyclic amines generated by pyrolysis of food have been suggested as potential dietary factors increasing the risk of bladder cancer, particularly in relation to the ingestion of red meat. Despite the existence of several identifiable factors that increase or decrease the risk of bladder cancer, many patients have no known carcinogens or risk factors.

Entities:  

Mesh:

Year:  2000        PMID: 11144890     DOI: 10.1080/00365590050509869

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  46 in total

1.  Urinary bladder cancer risk factors in Egypt: a multicenter case-control study.

Authors:  Yun-Ling Zheng; Sania Amr; Doa'a A Saleh; Chiranjeev Dash; Sameera Ezzat; Nabiel N Mikhail; Iman Gouda; Iman Loay; Tamer Hifnawy; Mohamed Abdel-Hamid; Hussein Khaled; Beverly Wolpert; Mohamed A Abdel-Aziz; Christopher A Loffredo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-06       Impact factor: 4.254

2.  CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies.

Authors:  Ming Yin; Jingrong Yan; Sheng Wei; Qingyi Wei
Journal:  Carcinogenesis       Date:  2010-02-22       Impact factor: 4.944

3.  Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.

Authors:  Qinbo Yuan; Meilin Wang; Miaomiao Wang; Zhengdong Zhang; Wei Zhang
Journal:  Mol Biol Rep       Date:  2011-07-13       Impact factor: 2.316

4.  Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies.

Authors:  Qingtong Ma; Yumei Zhao; Shoufeng Wang; Xiaoyan Zhang; Jinling Zhang; Mei Du; Liang Li; Yun Zhang
Journal:  Tumour Biol       Date:  2013-10-02

5.  Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.

Authors:  Mohammad Reza Safarinejad; Nayyer Shafiei; Shiva Safarinejad
Journal:  Med Oncol       Date:  2010-10-29       Impact factor: 3.064

6.  Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population.

Authors:  Meilin Wang; Haiyan Chu; Fu Yan; Chao Qin; Pu Li; Lin Yuan; Changjun Yin; Jianfeng Xu; Zhengdong Zhang
Journal:  Carcinogenesis       Date:  2011-03-31       Impact factor: 4.944

7.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.

Authors:  Xiao-Jun Wang; Zheng Sun; Weimin Chen; Kylee E Eblin; Jay A Gandolfi; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-07       Impact factor: 4.219

8.  COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.

Authors:  N V Chandrasekharan; Hu Dai; K Lamar Turepu Roos; Nathan K Evanson; Joshua Tomsik; Terry S Elton; Daniel L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

9.  Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis.

Authors:  Meilin Wang; Haixia Zhu; Guangbo Fu; Miaomiao Wang; Zhizhong Zhang; Qiang Lu; Shizhi Wang; Zhengdong Zhang
Journal:  Clin Exp Med       Date:  2008-09-25       Impact factor: 3.984

10.  Toll-like receptor 4 gene polymorphisms and susceptibility to bladder cancer.

Authors:  Yizhen Shen; Yi Liu; Shaoge Liu; Aimin Zhang
Journal:  Pathol Oncol Res       Date:  2012-10-12       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.